P.H.E. Hilkens

998 citations

18 papers · 514 · h-index 12

Impact in

Oncology top 10%
- Cancer Treatment and Pharmacology
Dermatology top 10%
- Chemotherapy-related skin toxicity

Papers in

Oncology 8
- Cancer Treatment and Pharmacology 8
Genetics 5
- Glioma Diagnosis and Treatment 5

Co-authors: Martin J. van den Bent (9 shared papers)G. Stoter (3 shared papers)Jaap Verweij (3 shared papers)Wim L.J. van Putten (5 shared papers)Ch.J. Vecht (4 shared papers)C. J. Vecht (2 shared papers)M.E.L. van der Burg (4 shared papers)Chantal Reusken (1 shared paper)
Journals: Neurology (2 papers)European Journal of Cancer (2 papers)Journal of Clinical Oncology (1 paper)BMC Medical Research Methodology (1 paper)European Stroke Journal (1 paper)
Partner nations: Netherlands United Kingdom

In The Last Decade

P.H.E. Hilkens

17 papers receiving 493 citations

Peers

Countries citing papers authored by P.H.E. Hilkens

Since Specialization

Citations

This map shows the geographic impact of P.H.E. Hilkens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.H.E. Hilkens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.H.E. Hilkens more than expected).

Fields of papers citing papers by P.H.E. Hilkens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.H.E. Hilkens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.H.E. Hilkens. The network helps show where P.H.E. Hilkens may publish in the future.

Co-authors

The 25 scholars most cited alongside P.H.E. Hilkens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with P.H.E. Hilkens Line = papers co-authored together P.H.E. Hilkens links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	Peripheral neurotoxicity induced by docetaxel Neurology ·P.H.E. Hilkens, Jaap Verweij, G. Stoter, Ch.J. Vecht, Wim L.J. van Putten, Martin J. van den Bent	1996	88
2	First autochthonous human West Nile virus infections in the Netherlands, July to August 2020 Eurosurveillance ·Danique RM Vlaskamp, Steven Thijsen, Johan Reimerink, P.H.E. Hilkens, Willem H. Bouvy, Sabine E. Bantjes, Bart J. M. Vlaminckx, Hans L. Zaaijer, Hans HTC van den Kerkhof, Stijn Raven, Chantal Reusken	2020	78
3	Clinical characteristics of severe peripheral neuropathy induced by docetaxel (Taxotere) Annals of Oncology ·P.H.E. Hilkens, Jaap Verweij, C. J. Vecht, G. Stoter, Martin J. van den Bent	1997	77
4	Chemotherapy-induced peripheral neuropathy. PubMed ·P.H.E. Hilkens, M J ven den Bent	1997	65
5	Phase I and pharmacologic study of docetaxel and cisplatin in patients with advanced solid tumors. Journal of Clinical Oncology ·L. Pronk, Jan H.M. Schellens, A.S.T. Planting, Martin J. van den Bent, P.H.E. Hilkens, M E van der Burg, M de Boer-Dennert, Jun Ma, (unknown), Miranda Harteveld, René Bruno, G. Stoter, Jaap Verweij	1997	61
6	Retreatment with dose-dense weekly cisplatin after previous cisplatin chemotherapy is not complicated by significant neuro-toxicity European Journal of Cancer ·Martin J. van den Bent, Wim L.J. van Putten, P.H.E. Hilkens, Ronald de Wit, M.E.L. van der Burg	2002	28
7	Lhermitte's sign following chemotherapy with docetaxel Neurology ·Martin J. van den Bent, P.H.E. Hilkens, Peter A.E. Sillevis Smitt, Vivian J.M. van Raaij‐van den Aarssen, M. Bontenbal, Jaco J. Verweij	1998	24
8	Value-based healthcare in ischemic stroke care: case-mix adjustment models for clinical and patient-reported outcomes BMC Medical Research Methodology ·Arvind Oemrawsingh, Nikki van Leeuwen, Esmée Venema, M. Limburg, Frank‐Erik de Leeuw, Markus P. J. M. Wijffels, Aafke J. de Groot, P.H.E. Hilkens, Jan A. Hazelzet, Diederik W.J. Dippel, C Bakker, Helene R. Voogdt-Pruis, Hester F. Lingsma	2019	20
9	Neurotoxicity is not enhanced by increased dose intensities of cisplatin administration European Journal of Cancer ·P.H.E. Hilkens, M.E.L. van der Burg, J. Moll, A.S.T. Planting, Wim L.J. van Putten, Ch.J. Vecht, Martin J. van den Bent	1995	18
10	Development of a patient decision aid for discharge planning of hospitalized patients with stroke BMC Neurology ·Janine Prick, Sander M. Van Schaik, Inger A. Deijle, R. Dahmen, Paul J.A.M. Brouwers, P.H.E. Hilkens, Mirjam M. Garvelink, Noel Engels, Jet W. Ankersmid, S.H.J. Keus, Regina The, Asako Takahashi, Cornelia F. van Uden‐Kraan, Philip J. van der Wees, Renske M. van den Berg‐Vos, (unknown), (unknown), Gert W. van Dijk, Rob A.R. Gons, Ritu Saxena, E.S. Schut	2022	11
11	Clinical course and risk factors of neurotoxicity following cisplatin in an intensive dosing schedule European Journal of Neurology ·P.H.E. Hilkens, André Planting, M.E.L. van der Burg, J. Moll, Wim L.J. van Putten, Ch.J. Vecht, Martin J. van den Bent	1994	11
12	Prevalence and risk factors of symptomatic carotid stenosis in patients with recent transient ischaemic attack or ischaemic stroke in the Netherlands European Stroke Journal ·Melina G.H.E. den Brok, Laurien S. Kuhrij, Bob Roozenbeek, Aad van der Lugt, P.H.E. Hilkens, Diederik W.J. Dippel, Paul J. Nederkoorn	2020	11
13	Normal pressure hydrocephalus associated with rheumatoid arthritis responding to prednisone. PubMed ·H. M. Markusse, P.H.E. Hilkens, Martin J. van den Bent, C. J. Vecht	1995	6
14	Increased frequency of CYP2C19 loss‐of‐function alleles in clopidogrel‐treated patients with recurrent cerebral ischemia British Journal of Clinical Pharmacology ·Crista Minderhoud, Leila S. Otten, P.H.E. Hilkens, Marcel P. H. van den Broek, Ankie M. Harmsze	2022	5
15	Non-convulsive status epilepticus as cause for focal neurological deficit Acta Neurologica Scandinavica ·P.H.E. Hilkens, A.W. de Weerd	2009	5
16	Manual vs. automated analysis of polysomnographic recordings in patients with chronic obstructive pulmonary disease Sleep And Breathing ·Gerben Stege, Petra J.E. Vos, P. N. Richard Dekhuijzen, P.H.E. Hilkens, Marjo J.T. van de Ven, Yvonne F. Heijdra, Frank J.J. van den Elshout	2012	3
17	Effect of an ACTH(4–9) analogue on cisplatin neuropathy of longstanding duration: a phase II study Clinical Neurology and Neurosurgery ·P.H.E. Hilkens, M.E.L. van der Burg, J. Moll, Martin J. van den Bent, Wim L.J. van Putten, Ch.J. Vecht	1995	3
18	Shared Decision-Making Supported by Outcome Information During Discharge Planning of Patients Hospitalized With Stroke Neurology Clinical Practice ·Janine Prick, Marjon V. Verschueren, Inger A. Deijle, S.M. van Schaik, R. Dahmen, Paul J.A.M. Brouwers, (unknown), P.H.E. Hilkens, Mirjam M. Garvelink, R. Saxena, Rob A.R. Gons, E.S. Schut, Michelle F. M. ten Brinck, S.H.J. Keus, Noel Engels, J.W. Ankersmid-Matos Miguel, Mariska Q.N. Hackert, Steven Teerenstra, Cornelia F. van Uden‐Kraan, Philip J. van der Wees, Renske M. van den Berg‐Vos	2025	0

About P.H.E. Hilkens

P.H.E. Hilkens is a scholar working on Oncology, Genetics, Pulmonary and Respiratory Medicine, Surgery and Hematology, having authored 18 papers that have together received 514 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (8 papers), Glioma Diagnosis and Treatment (5 papers), Multiple Myeloma Research and Treatments (3 papers), Brain Metastases and Treatment (3 papers), Patient Satisfaction in Healthcare (1 paper), Epilepsy research and treatment (1 paper), Neurological disorders and treatments (1 paper) and Management of metastatic bone disease (1 paper). The work is most often cited by research in Oncology (254 citations), Dermatology (60 citations), Hematology (65 citations), Genetics (48 citations) and Otorhinolaryngology (16 citations). P.H.E. Hilkens has collaborated with scholars based in Netherlands and United Kingdom. Frequent co-authors include Martin J. van den Bent, G. Stoter, Jaap Verweij, Wim L.J. van Putten, Ch.J. Vecht, C. J. Vecht, M.E.L. van der Burg, Chantal Reusken, Bart J. M. Vlaminckx and Hans L. Zaaijer. Their work appears in journals such as Neurology, European Journal of Cancer, Journal of Clinical Oncology, BMC Medical Research Methodology and European Stroke Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

P.H.E. Hilkens

Impact in

Papers in i

In The Last Decade

P.H.E. Hilkens

Peers

Countries citing papers authored by P.H.E. Hilkens

Fields of papers citing papers by P.H.E. Hilkens

All Works

About P.H.E. Hilkens

Explore authors with similar magnitude of impact

Papers in